» Articles » PMID: 28704212

Endoscopic Mucosal Resection and Endoscopic Submucosal Dissection: Technique and New Directions

Overview
Specialty Gastroenterology
Date 2017 Jul 14
PMID 28704212
Citations 61
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose Of Review: Most of small tumours in gastrointestinal tract are easily removed by endoscopic mucosal resection (EMR). However, EMR are sometimes not reliable to ensure the complete resection for large tumours. Although endoscopic submucosal dissection (ESD) was developed, it had a higher risk for complications such as perforation and bleeding. The techniques and clinical outcomes of EMR and ESD are reviewed.

Recent Findings: ESD is more effective for early gastric and oesophageal cancer with higher en-bloc resection rate and lower local recurrence in comparison to EMR. Several studies report favourable long-term outcomes of ESD. ESD has become a standard technique in Japan and other East Asian countries. Piecemeal resection using EMR technique is widely accepted for colorectal large adenomas and results in good clinical outcomes in most patients. However, apparent cancerous lesions need endoscopic en-bloc resection by ESD.

Summary: Further development of the technique, devices and training systems will promote worldwide standardization of ESD.

Citing Articles

Novel device for blunt dissection in third space endoscopy: Preliminary animal study (with video).

Yokouchi T, Masunaga T, Miyazaki K, Kato M, Fujii S, Momose K Endosc Int Open. 2025; 13:a25145464.

PMID: 40007655 PMC: 11855248. DOI: 10.1055/a-2514-5464.


Dexmedetomidine as an Adjunctive Sedative in Patients Undergoing Endoscopic Submucosal Dissection: A Systematic Review and Meta-Analysis.

Abosheaishaa H, Abdallfatah A, Abdelghany A, Sethi A, Ismail A, Mohamed D medRxiv. 2024; .

PMID: 39677437 PMC: 11643290. DOI: 10.1101/2024.11.14.24317324.


Addition of Dexmedetomidine to the Anesthesia Regimen Attenuates Pain and Improves Early Recovery After Esophageal Endoscopic Submucosal Dissection: A Randomized Controlled Trial.

Luo X, Hou H, Chen P, Chang X, Li Y, An L Drug Des Devel Ther. 2024; 18:4551-4562.

PMID: 39411154 PMC: 11476426. DOI: 10.2147/DDDT.S475749.


Endoscopic Submucosal Dissection for Early Gastric Cancer Exceeding Expanded Criteria-Long-Term Outcomes from the German ESD Registry.

Riedl K, Probst A, Ebigbo A, Steinbruck I, Allgaier H, Albers D J Clin Med. 2024; 13(18).

PMID: 39337025 PMC: 11432303. DOI: 10.3390/jcm13185538.


Development of a hybrid hydrogel for submucosal injection in endoscopic resection of gastrointestinal neoplasm: From laboratory to clinical trial.

Kang J, Chen P, Chen C, Riley G, Wang Y, Kuo H Endosc Int Open. 2024; 11(11):E1026-E1034.

PMID: 38835638 PMC: 11148844. DOI: 10.1055/a-2161-2100.